JP2025032191A5 - - Google Patents
Info
- Publication number
- JP2025032191A5 JP2025032191A5 JP2024210953A JP2024210953A JP2025032191A5 JP 2025032191 A5 JP2025032191 A5 JP 2025032191A5 JP 2024210953 A JP2024210953 A JP 2024210953A JP 2024210953 A JP2024210953 A JP 2024210953A JP 2025032191 A5 JP2025032191 A5 JP 2025032191A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962800056P | 2019-02-01 | 2019-02-01 | |
| US62/800,056 | 2019-02-01 | ||
| JP2021544728A JP2022523123A (ja) | 2019-02-01 | 2020-01-31 | 神経認知障害を処置するための組成物及び方法 |
| PCT/US2020/016163 WO2020160441A1 (en) | 2019-02-01 | 2020-01-31 | Compositions and methods for treating neurocognitive disorders |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544728A Division JP2022523123A (ja) | 2019-02-01 | 2020-01-31 | 神経認知障害を処置するための組成物及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025032191A JP2025032191A (ja) | 2025-03-11 |
| JP2025032191A5 true JP2025032191A5 (enExample) | 2025-08-19 |
Family
ID=71841290
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544728A Pending JP2022523123A (ja) | 2019-02-01 | 2020-01-31 | 神経認知障害を処置するための組成物及び方法 |
| JP2024210953A Pending JP2025032191A (ja) | 2019-02-01 | 2024-12-04 | 神経認知障害を処置するための組成物及び方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544728A Pending JP2022523123A (ja) | 2019-02-01 | 2020-01-31 | 神経認知障害を処置するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220133850A1 (enExample) |
| EP (1) | EP3917623A4 (enExample) |
| JP (2) | JP2022523123A (enExample) |
| CA (1) | CA3127804A1 (enExample) |
| IL (1) | IL285268A (enExample) |
| MA (1) | MA54873A (enExample) |
| WO (1) | WO2020160441A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190248A1 (ar) | 2017-04-21 | 2019-10-20 | Amgen Inc | بروتينات ربط مولد ضد trem2 واستخداماته |
| WO2022006105A2 (en) * | 2020-07-02 | 2022-01-06 | Avrobio, Inc. | Compositions and methods for treating neurocognitive disorders |
| IL316123A (en) * | 2022-04-07 | 2024-12-01 | Univ California | Methods for treating Alzheimer's disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002347563A1 (en) * | 2001-12-06 | 2003-06-17 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders |
| WO2014074942A1 (en) * | 2012-11-08 | 2014-05-15 | Illumina, Inc. | Risk variants of alzheimer's disease |
| WO2017147509A1 (en) * | 2016-02-25 | 2017-08-31 | Marco Colonna | Compositions comprising trem2 and methods of use thereof |
| EP3487886A2 (en) * | 2016-07-22 | 2019-05-29 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) | Trem2 cleavage modulators and uses thereof |
| BR112020001060A2 (pt) * | 2017-07-27 | 2020-07-14 | Novartis Ag | variantes de trem2 resistentes a shedase |
-
2020
- 2020-01-31 MA MA054873A patent/MA54873A/fr unknown
- 2020-01-31 EP EP20748276.1A patent/EP3917623A4/en active Pending
- 2020-01-31 JP JP2021544728A patent/JP2022523123A/ja active Pending
- 2020-01-31 WO PCT/US2020/016163 patent/WO2020160441A1/en not_active Ceased
- 2020-01-31 US US17/427,429 patent/US20220133850A1/en active Pending
- 2020-01-31 CA CA3127804A patent/CA3127804A1/en active Pending
-
2021
- 2021-08-01 IL IL285268A patent/IL285268A/en unknown
-
2024
- 2024-12-04 JP JP2024210953A patent/JP2025032191A/ja active Pending